title: Extreme creatine phosphokinase elevation in a 20-year-old man participating in a clinical trial of major depressive disorder.
authors.forename: Thomas M
authors.initials: TM
authors.lastname: Shiovitz
authors.forename: Joo Lee
authors.initials: JL
authors.lastname: Song
authors.forename: N Bailey
authors.initials: NB
authors.lastname: Manlosa
authors.forename: Maria I
authors.initials: MI
authors.lastname: Seliverstov
authors.forename: Salila
authors.initials: S
authors.lastname: Sharma
mesh_terms: D000081:Acetamides / Q000627:therapeutic use; D000328:Adult; D003402:Creatine Kinase / Q000097:blood*; D003865:Major Depressive Disorder / Q000188:drug therapy*; D003951:Diagnostic Errors; D019587:Dietary Supplements / Q000009:adverse effects*; D016903:Drug Monitoring; D015444:Exercise; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D008297:Male; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis*; D016032:Randomized Controlled Trials as Topic; D009281:Naphthalenes
chemical_list: D000081:Acetamides; D003402:Creatine Kinase; D006993:Hypnotics and Sedatives; C084711:agomelatine; D009281:Naphthalenes